Advertisement

Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px
Organisation › Details

Relyens (Group)

Launched in 2014, Relyens Innovation Santé is is an evergreen venture capital vehicle specializing in health innovation controlled and owned by Relyens, a mutual insurance company specializing in the risk management of health, social and medical players. Relyens is the leading French player in medical civil liability. Advised by Turenne Santé (Health Division of Turenne Group), Relyens Innovation Santé’s mission is to support the growth and development phases of innovative companies in the health sector. *

 

Period Start 2014-01-01 existent
Product Industry  HEALTH (HUMAN)
     
Region Region France_oo
  Country France
  City n. a. 
    Address record changed: 2023-04-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: AlgoTherapeutix SAS. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes.
     
   
Record changed: 2025-03-16

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x200px

More documents for Relyens (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x300px




» top